BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2867492)

  • 1. [Our experience on the clinical use of nadolol].
    Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
    Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
    [No Abstract]   [Full Text] [Related]  

  • 2. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of nadolol in angina pectoris.
    Cruz J; Conceicao JM; Coelho EM
    Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
    [No Abstract]   [Full Text] [Related]  

  • 4. Nadolol (Corgard) - a new beta-blocker.
    Med Lett Drugs Ther; 1980 Apr; 22(8):33-4. PubMed ID: 6102734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation, by the bicycle ergometry test ECG, of the efficacy of a single dosage of nadolol, in patients with stable angina pectoris].
    Capuano V; De Vita S; Riccio MD; De Martino M; Mondillo G
    Minerva Cardioangiol; 1985 Nov; 33(11):739-44. PubMed ID: 2868431
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of the anti-angina effectiveness of nadolol and propranolol].
    Cremonesi A; Pagliarani PL; Guelfi P; Mattace R; Costa G; Bernardi G; Zacà F
    Boll Soc Ital Cardiol; 1979; 24(7):741-5. PubMed ID: 45306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
    Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
    Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of hypotensive effect of nadolol].
    Cybulska I; Brym E; Czerniewska E; Wołyńczyk-Niegowska J
    Pol Arch Med Wewn; 1980 Dec; 64(6):475-80. PubMed ID: 6111065
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of metoprolol and trichlormethiazide in hypertension.
    Stokkeland OM; Sangvik K; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):755-68. PubMed ID: 2449
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 12. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP; Lamon KD; Hagen NS
    J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 14. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of beta-adrenergic blockers in the treatment of angina and hypertension. A clinical symposium. 31st annual meeting, American College of Angiology and 21st annual meeting, International College of Angiology. San Antonio, Texas, November 6, 1984.
    Angiology; 1986 Mar; 37(3 Pt 2):215-62. PubMed ID: 2871778
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of essential hypertension using a new beta-receptor blockader (timolol maleate) combined with hydrochlorothiazide].
    Heinze A; Wessels F
    Verh Dtsch Ges Inn Med; 1974; 80():272-4. PubMed ID: 4156115
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term experience with nadolol in treatment of hypertension and angina pectoris.
    Alexander JC; Christie MH; Vernam KA; Fand RS; Shafer WB
    Am Heart J; 1984 Oct; 108(4 Pt 2):1136-40. PubMed ID: 6148874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of metoprolol on systolic time in patients with stable angina pectoris].
    Mosti G; Tomei G; Veltri M; Giusti C
    Minerva Cardioangiol; 1979 Mar; 27(3):147-52. PubMed ID: 37463
    [No Abstract]   [Full Text] [Related]  

  • 19. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

  • 20. [New specialty drugs registered in Austria. Concor].
    Graffius D
    Wien Klin Wochenschr; 1990 Mar; 102(6):180-4. PubMed ID: 1970446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.